Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Anesthesia for Breast Cancer Surgery
NCT03117894Completed
- Sponsor
- Umeå University
- Start
- May 2017
- Primary completion
- Oct 2020
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised trial of ropivacaine hydrochloride liposomal suspension injection in breast cancer (2 arms), sponsored by Umeå University. Primary endpoints: Opiate consumption at 48 hours and All cause mortality at 5 years. Started May 2017; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03117894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03117894.